Kazia Therapeutics Limited (NASDAQ: KZIA) ("Kazia" or the "Company"), an oncology-focused drug development company, today ...

Even though lung and related cancer deaths decreased in the world's 10 most populous countries from 1990 to 2019, these ...

Aakash Chopra highlights concerns over the readiness of venues for the 2025 Champions Trophy in Pakistan, warning that the ...

For patients with advanced or recurrent endometrial cancer, first-line Lenvima plus Keytruda didn’t significantly improve ...

Round Three of the Investec Champions Cup takes place this weekend and there's some tasty fixtures on the schedule, notably ...

Clearly, Blair Kinghorn's Toulouse are red-hot favourites. You have Johnny Gray's Bordeaux and La Rochelle as well from ...

Making some educated guesses and using the current landscape of WWE’s booking and roster, we predict the next few Undisputed ...

TrialTranslator uses machine learning to assess cancer RCT generalizability, revealing survival gaps for high-risk patients ...

Romania's Sibiu County Emergency Clinical Hospital will receive a robotic system to prepare cytostatic drugs needed by cancer ...

Boehringer Ingelheim announced a partnership with Synaffix to advance antibody-drug conjugates and exercised its fourth ...

Light Horse’s CEO said the biotech’s initial focus will be on “high-value and historically challenging” oncology targets.

Multiple TIGIT clinical data readouts anticipated throughout 2025, including >400 patients from two Phase 2 trials and one Phase 1/2 ...